Biodexa Pharmaceuticals Plc
Biodexa Pharmaceuticals Plc (BDRX) Revenue
Annual & quarterly revenue history · segment & region breakdown
BDRX · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsBiodexa Pharmaceuticals Plc trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Biodexa Pharmaceuticals Plc receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Biodexa Pharmaceuticals Plc reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Biodexa Pharmaceuticals Plc's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BDRX revenue · 4 questionsBDRX's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Biodexa Pharmaceuticals Plc SEC filings · GAAP · Biodexa Pharmaceuticals Plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026